CECLOR
LOE ApproachingNDAORALCAPSULE
Approved
Apr 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CECLOR is an oral cephalosporin antibiotic approved in 1979 for bacterial infections. The drug is a small-molecule broad-spectrum beta-lactam antibiotic used to treat respiratory, urinary, skin, and soft tissue infections. It remains a mature, widely-used agent in primary care and community settings.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), the brand team is likely in transition mode with reduced headcount and budget focus on retention and cost management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CECLOR offers minimal career growth opportunity given its LOE-approaching lifecycle stage and zero linked job openings. Roles are primarily defensive (maintenance of existing business) rather than growth-oriented, making this a low-priority assignment for ambitious professionals.
Brand ManagerField Sales Representative
Worked on CECLOR at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.